Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

Read More

Overview

Feature Articles

Latest Multiple Myeloma News and Research

People with blood-related cancers more likely to experience COVID breakthrough infections

People with blood-related cancers more likely to experience COVID breakthrough infections

Big pharma went all in to kill drug pricing negotiations

Big pharma went all in to kill drug pricing negotiations

Alliance MCED Biobank Study may provide greater understanding of how to detect multiple cancers

Alliance MCED Biobank Study may provide greater understanding of how to detect multiple cancers

Study examines the feasibility of patient engagement with digital life coaching during stem cell transplant

Study examines the feasibility of patient engagement with digital life coaching during stem cell transplant

New 'decoy receptor' molecules inhibit growth of multiple myeloma and diffuse large B cell lymphoma in mice

New 'decoy receptor' molecules inhibit growth of multiple myeloma and diffuse large B cell lymphoma in mice

Improving the immune defenses against blood cancer

Improving the immune defenses against blood cancer

Caregivers for patients with multiple myeloma may suffer from anxiety and depression

Caregivers for patients with multiple myeloma may suffer from anxiety and depression

Stem cell transplantation produces prolonged survival with improved safety in patients with AL amyloidosis

Stem cell transplantation produces prolonged survival with improved safety in patients with AL amyloidosis

Study highlights need to prioritize immunocompromised COVID patients

Study highlights need to prioritize immunocompromised COVID patients

Researchers find a way to kill recurring prostate cancer with a lot of iron

Researchers find a way to kill recurring prostate cancer with a lot of iron

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Treatment with immunity-boosting protein enhances the function of CAR-T cells in fighting blood cancers

Treatment with immunity-boosting protein enhances the function of CAR-T cells in fighting blood cancers

AI tool allows clinicians to make optimal, personalized chemotherapy doses for patients

AI tool allows clinicians to make optimal, personalized chemotherapy doses for patients

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Risk factors for COVID-19 in patients with hematological malignancies

Risk factors for COVID-19 in patients with hematological malignancies

Standard blood cancer test holds clear clues of rare IgD multiple myeloma

Standard blood cancer test holds clear clues of rare IgD multiple myeloma

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

Obesity plus alcohol intake may increase risk of developing alcohol-related cancer

Obesity plus alcohol intake may increase risk of developing alcohol-related cancer

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Black and Hispanic people get the same benefits from CAR-T therapy as white patients

Black and Hispanic people get the same benefits from CAR-T therapy as white patients